Phase II Study of Antineoplastons A10 and AS2-1 In Children With Primitive Neuroectodermal Tumors.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- Acronyms PNET
- 22 Sep 2016 Status changed from active, no longer recruiting to completed.
- 21 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Aug 2005 New trial record.